(Reuters) – Abbott Laboratories reported a 70.5% rise in quarterly profit on Wednesday, helped by strength in its medical device and diagnostics businesses and a rebound in COVID-19 test sales due to the spread of the Delta variant of the coronavirus.
The company’s net earnings rose to $2.1 billion, or $1.17 per share, in the third quarter ended Sept. 30, from $1.23 billion, or 69 cents per share, a year earlier.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Sriraj Kalluvila)
